Four weeks after a puzzling outbreak was reported in the Democratic Republic of Congo, the World Health Organization has ...
Resomelagon is under clinical development by SynAct Pharma and currently in Phase II for Coronavirus Disease 2019 (COVID-19) Associated Acute Respiratory Distress Syndrome.
As for testing, the girl's first swab at BC Children's was positive for influenza A but negative for H1 or H3 disease.
Wastewater surveillance suggests that we in the midst of what's being called a "Silent" COVID-19 surge fueled by the XEC ...
Data for acute respiratory diseases showed an upward trend in overall infections in the week of Dec. 16 to 22, according to an official statement released on Thursday. China is likely to be ...
WHO links mystery illness in DR Congo to malaria and viral respiratory infections Kinsasha, DRC | THE INDEPENDENT | The World ...
A combination of viral respiratory infections, malaria and malnutrition has killed nearly 50 people in the African country.
Despite the rising number of cases, experts emphasised caution in using antiviral drugs indiscriminately for hMPV.
A mysterious illness outbreak in a remote region of the Democratic Republic of Congo has now been identified as an acute ...
China is piloting a monitoring system for pneumonia of unknown origin, anticipating a rise in respiratory diseases during ...
A leading epidemiologist has said that levels of human metapneumovirus (HMPV) remained low in Hong Kong amid an outbreak of ...
MP-1032 is under clinical development by MetrioPharm and currently in Phase I for Inflammatory Bowel Disease. According to GlobalData, Phase I drugs for Inflammatory Bowel Disease have a 73% phase ...